Concepedia

Leonard C. Weir

LC

Statistics

Publications

7

Citations

444

H-Index

7

Active since

1995

Affiliations

Eli Lilly (United States)(Current)

Leonard C. Weir is an author at Eli Lilly (United States) specializing in medicinal chemistry, enzyme inhibition, and drug discovery.

Publications per year

1995–2003

7

Publications

7

Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain

J. Scott Sawyer, Bryan D. Anderson, Douglas W. Beight et al. · Journal of Medicinal Chemistry · 2003 · 237 citations · Full text

, , +17

<i>N</i><sup>2</sup>-Aroylanthranilamide Inhibitors of Human Factor Xa

Ying K. Yee, Anne Louise Tebbe, Jared H. Linebarger et al. · Journal of Medicinal Chemistry · 2000 · 48 citations

, , +10

Structure-Based Design of Potent, Amidine-Derived Inhibitors of Factor Xa:  Evaluation of Selectivity, Anticoagulant Activity, and Antithrombotic Activity

Michael R. Wiley, Leonard C. Weir, Steven L. Briggs et al. · Journal of Medicinal Chemistry · 2000 · 46 citations

, , +16

D-Phe-Pro-p-Amidinobenzylamine: A potent and highly selective thrombin inhibitor

Michael R. Wiley, Nickolay Y. Chirgadze, David K. Clawson et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 41 citations

, , +9

Serine protease selectivity of the thrombin inhibitor D-Phe-Pro-Agmatine and its homologs

Michael R. Wiley, Nickolay Y. Chirgadze, David K. Clawson et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 36 citations

, , +11

1–5 of 7